Try our Advanced Search for more refined results
March 12, 2020
MCDERMID v. INOVIO PHARMACEUTICALS, INC. et al
Case Number:
2:20-cv-01402
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Class Action
Judge:
Firms
- Berger Montague
- Block & Leviton
- Cooley LLP
- Donovan Litigation
- Duane Morris
- Glancy Prongay
- Goldman Scarlato
- Kohn Swift
- Robbins Geller
- Sacks Weston
- Shuman Glenn
- Wolf Haldenstein
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 18, 2023
Investors, Inovio Get Final OK For $44M Deal In Stock Suit
A Pennsylvania federal judge on Wednesday approved a $44 million deal between biotechnology firm Inovio Pharmaceuticals Inc. and its investors to resolve claims that the company's alleged misrepresentation of its COVID-19 vaccine development efforts in early 2020 prompted its stock price to plunge.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login